New injection shows promise for lowering cholesterol in indian patients
NCT ID NCT06386419
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested the safety and effectiveness of inclisiran sodium, a cholesterol-lowering injection, in 65 Indian adults with high cholesterol or mixed dyslipidemia. Participants received three doses over 270 days. The goal was to see how well it lowers LDL cholesterol and if any side effects occur.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
inclisiran sodium
What this could lead to
If successful, this could confirm that inclisiran is a safe and effective option for lowering cholesterol in Indian patients, offering a convenient injection schedule.
What could go wrong
This is a small, completed Phase 4 study with only 65 participants, so results may not apply to everyone. Side effects or lack of effectiveness are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Bangalore, Karnataka, 560099, India
-
Novartis Investigative Site
Belagavi, Karnataka, 590010, India
-
Novartis Investigative Site
Mumbai, Maharashtra, 400012, India
-
Novartis Investigative Site
Nagpur, Maharashtra, 441108, India
-
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, 110029, India
-
Novartis Investigative Site
Jaipur, Rajasthan, 302039, India
-
Novartis Investigative Site
Madurai, Tamil Nadu, 625107, India
-
Novartis Investigative Site
Vellore, Tamil Nadu, 632 004, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700 020, India